LAURO CERDAN: Open Payments
NPI 1922126002 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,835 in 19 payments from 13 companies in 2025. Trend: 2023 $1,149 · 2024 $1,703 · 2025 $6,835
Consulting: $5,161Food & beverage: $1,643Travel & lodging: $31
| Company | Payments | Amount |
|---|---|---|
| Ethicon Inc. | 2 | $5,192 |
| ABBVIE INC. | 2 | $250 |
| Amgen Inc. | 2 | $225 |
| MIMEDX Group, Inc. | 3 | $196 |
| Gilead Sciences, Inc. | 2 | $146 |
| PharmaEssentia USA Corporation | 1 | $143 |
| ABIOMED | 1 | $126 |
| Alcresta Therapeutics, Inc. | 1 | $124 |
| La Jolla Pharmaceutical Company | 1 | $122 |
| Mallinckrodt Hospital Products Inc. | 1 | $108 |
Products named: Livdelzi, BESREMI, EMBLAVEO, RELIZORB, ZEVTERA, TERLIVAZ, JOURNAVX, Leqembi.
Industry payments across TX — which companies pay providers there.
